title: Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery.
abstract: BACKGROUND
  The scavenger receptor for complexes hemoglobin-haptoglobin (CD163), which is expressed on monocytes/ macrophages, is shed to the body fluids in a soluble form (sCD163).
  
  
  OBJECTIVE
  To evaluate the dynamics of sCD163 in the blood of patients undergoing cardiac surgery.
  
  
  METHODS
  Sixty-one adult patients who underwent coronary artery bypass grafting (CABG) were enrolled in the study. They were assigned to undergo CABG using either cardiopulmonary bypass (CPB), "on-pump", (22 patients), modified CPB, mini "on-pump", (17 patients) or without CPB, "off-pump", (22 patients) surgery. Serum levels of sCD163 in venous blood samples taken before and after surgery, and during an early postoperative period, were evaluated by Macro 163(TM) diagnostic kit (IQ Products, Groningen, NL).
  
  
  RESULTS
  Compared to the preoperative levels ("on-pump"; 344 ng/mL, "off-pump"; 314.5 ng/mL, mini-invasive "on-pump"; 336.5 ng/mL) serum levels were elevated at the finish of surgery, reaching maximum at the 1(st) postoperative day ("onpump"; 658 ng/mL; p<0.05, "off-pump"; 810.5 ng/mL; p<0.01; mini-invasive "on-pump"; 663 ng/mL; non-significant).No significant differences regarding the serum levels of sCD163 between different surgical approaches were found.
  
  
  CONCLUSIONS
  Serum level of sCD163 scavenger molecule for hemoglobin is elevated at the end of surgery and at the 1(st) postoperative day, being little influenced by cardiopulmonary bypass.
authors.affiliation: Department of Clinical Immunology and Allergy, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.
authors.forename: Martina
authors.initials: M
authors.lastname: Kolackova
authors.forename: Vladimir
authors.initials: V
authors.lastname: Lonsky
authors.forename: Manuela
authors.initials: M
authors.lastname: Trojackova Kudlova
authors.forename: Jiri
authors.initials: J
authors.lastname: Mandak
authors.forename: Pavel
authors.initials: P
authors.lastname: Kunes
authors.forename: Vladimir
authors.initials: V
authors.lastname: Svitek
authors.forename: Karolina
authors.initials: K
authors.lastname: Jankovicova
authors.forename: Dana
authors.initials: D
authors.lastname: Vlaskova
authors.forename: Ctirad
authors.initials: C
authors.lastname: Andrys
authors.forename: Jan
authors.initials: J
authors.lastname: Krejsek
mesh_terms: D000368:Aged; D015703:Antigens, CD / Q000097:blood*; D015214:Antigens, Differentiation, Myelomonocytic / Q000097:blood*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005260:Female; D006242:Haptoglobins / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011956:Receptors, Cell Surface / Q000097:blood*; D000098902:CD163 Antigen
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D000098902:CD163 Antigen; D006242:Haptoglobins; D006454:Hemoglobins; D011956:Receptors, Cell Surface; C035492:haptoglobin-hemoglobin complex